(NASDAQ: MLEC) Moolec Science Sa's forecast annual revenue growth rate of -13.8% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Moolec Science Sa's revenue in 2026 is $336,139,113.On average, 3 Wall Street analysts forecast MLEC's revenue for 2027 to be $57,274,246, with the lowest MLEC revenue forecast at $55,027,628, and the highest MLEC revenue forecast at $58,958,847. On average, 3 Wall Street analysts forecast MLEC's revenue for 2028 to be $96,857,280, with the lowest MLEC revenue forecast at $93,052,406, and the highest MLEC revenue forecast at $99,703,675.
In 2029, MLEC is forecast to generate $160,334,778 in revenue, with the lowest revenue forecast at $154,046,570 and the highest revenue forecast at $165,047,303.